Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IOL Chemicals And PharmaceuticalsNSE:IOLCP -0.32%59 Days Sales Outstanding is 72.77 as of Jun. 2026, which is 23% above its 10-year median of 59.27. GuruFocus rates NSE:IOLCP with a GF Score™ of 59/100 and a GF Value™ of ₹91.08 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 947 Drug Manufacturers companies, IOL Chemicals And Pharmaceuticals ranks worse than 62.72% on this metric.
The historical rank and industry rank for IOL Chemicals And Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:
NSE:IOLCP'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 38.08 Med: 59.27 Max: 88.32
Current: 86.04
During the past 13 years, IOL Chemicals And Pharmaceuticals's highest Days Sales Outstanding was 88.32. The lowest was 38.08. And the median was 59.27.
NSE:IOLCP's Days Sales Outstanding is ranked worse than 62.72% of 947
companies
in the Drug Manufacturers industry
Industry Median: 71.98
vs NSE:IOLCP: 86.04
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IOL Chemicals And Pharmaceuticals Days Sales Outstanding Chart
NSE:IOLCP vs ZTS: Days Sales Outstanding Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, IOL Chemicals And Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IOL Chemicals And Pharmaceuticals Days Sales Outstanding vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, IOL Chemicals And Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where IOL Chemicals And Pharmaceuticals's Days Sales Outstanding falls into.
IOL Chemicals And Pharmaceuticals Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) has a Days Sales Outstanding of 72.77 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. This is 23% above median its historical median of 59.27. Over the past decade, IOL Chemicals And Pharmaceuticals' Days Sales Outstanding has ranged from 38.08 to 88.32. According to the industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #594 out of 947 companies in the Drug Manufacturers industry, placing it in the top 62.7%.
Is IOL Chemicals And Pharmaceuticals' Days Sales Outstanding too high?
IOL Chemicals And Pharmaceuticals' current Days Sales Outstanding of 72.77 is 23% above median its 10-year median of 59.27. Over the past 10 years, this metric has ranged from a low of 38.08 to a high of 88.32. The Drug Manufacturers industry median Days Sales Outstanding is 71.98. IOL Chemicals And Pharmaceuticals' value of 72.77 is 1.1% above this industry median. Based on the distribution chart, IOL Chemicals And Pharmaceuticals ranks #594 out of 947 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, IOL Chemicals And Pharmaceuticals has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IOL Chemicals And Pharmaceuticals' Days Sales Outstanding compare to ZTS?
According to the Drug Manufacturers industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #594 out of 947 companies for Days Sales Outstanding. This places IOL Chemicals And Pharmaceuticals in the lower half of its industry. The industry median Days Sales Outstanding is 71.98. IOL Chemicals And Pharmaceuticals' value of 72.77 is 1.1% above this benchmark. Historically, IOL Chemicals And Pharmaceuticals' own Days Sales Outstanding has ranged from 38.08 to 88.32 over the past decade. While the company's 10-year median is 59.27 vs. the industry median of 71.98, IOL Chemicals And Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Drug Manufacturers company?
The median Days Sales Outstanding among Drug Manufacturers companies is 71.98, based on 947 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IOL Chemicals And Pharmaceuticals's current Days Sales Outstanding of 72.77 is 1.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Sales Outstanding is 71.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IOL Chemicals And Pharmaceuticals's current Days Sales Outstanding is 72.77, which is 23% above median its own 10-year median of 59.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IOL Chemicals And Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals (NSE:IOLCP) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹91.08, compared to a current price of ₹164.14 — trading 80.2% above its estimated fair value. The current Days Sales Outstanding is 72.77, which is 23% above median its 10-year median of 59.27 and 1.1% above the Drug Manufacturers industry median of 71.98. IOL Chemicals And Pharmaceuticals' overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For IOL Chemicals And Pharmaceuticals (NSE:IOLCP), the current Days Sales Outstanding is 72.77 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Overvalued in 2026?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹164.14 is trading 80.2% above its estimated GF Value™ of ₹91.08.
GuruFocus considers IOL Chemicals And Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for NSE:IOLCP:
Days Sales Outstanding: 72.77 (23% above median its 10-year median of 59.27)
GF Value™: ₹91.08 vs. price of ₹164.14 (80.2% above fair value)
Industry Position: 1.1% above the Drug Manufacturers median (#594 of 947)
No single metric tells the full story. See the NSE:IOLCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.
59GF Score
Get the complete analysis for NSE:IOLCP
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:IOLCP has been successfully added to your 
